IGBA welcomes new chair and new full member (January 2025)
IGBA, the International Generic and Biosimilar Medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, announced today that Shinichiro Hirose, Director of International Affairs at the Japanese Generic Medicines Association (JGA) is taking over the position of IGBA Chair for 2025 from Adrian van den Hoven, Director of Medicines for Europe. Jim Keon, President of the Canadian Generic Pharmaceutical Association, will take over the position of IGBA Vice-Chair for 2025.
